Labcad 100 is a prescription oral antihypertensive medication containing Labetalol 100 mg, a dual-action beta-blocker with both alpha- and beta-adrenergic blocking properties. It is used primarily for the management of high blood pressure (hypertension), including chronic hypertension and hypertensive emergencies, offering effective control over elevated blood pressure to reduce the risk of stroke, heart attack, and kidney damage.
What sets Labetalol apart from other beta-blockers is its combined blockade of beta receptors (which reduce heart rate and cardiac output) and alpha receptors (which relax blood vessels), resulting in a balanced and sustained antihypertensive effect without a significant drop in heart function or perfusion. This makes Labcad 100 particularly valuable in patients with coexisting cardiovascular conditions or during pregnancy-induced hypertension (under careful supervision).
The medication works by lowering the resistance in blood vessels and slowing the heart rate, which helps reduce the workload on the heart and maintain steady blood circulation. It is especially useful for patients who need a rapid yet well-tolerated blood pressure control.
Labcad 100 can be administered as monotherapy or in combination with other antihypertensives depending on the severity of the condition and the individual’s clinical profile. It is important that patients follow the prescribed dosage regimen strictly, as abrupt withdrawal may result in rebound hypertension or other cardiovascular complications.
It should be used cautiously in patients with asthma, diabetes, liver dysfunction, or peripheral vascular diseases. Patients should be regularly monitored for heart rate, blood pressure, and signs of orthostatic hypotension during treatment.